| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |